Latest Schedule 13D activist filings

Maple Rock Capital Partners Inc. and Xavier Majic have increased their beneficial ownership in Algoma Steel Group Inc. to 9.9%.

Viking Global Investors LP and affiliates updated their beneficial ownership in BridgeBio Pharma, Inc., reporting a net reduction in shares since July 1, 2025.

A group led by Clint D. Coghill, a director of Amplify Energy Corp., increased its beneficial ownership in the company to 8.9% through recent share purchases.

SR One Capital Management and its affiliated funds have reported a decrease in their beneficial ownership of ORIC Pharmaceuticals, Inc. common stock to below 5%.

RA Capital Management and its affiliates have increased their beneficial ownership in Solid Biosciences Inc. to 9.9% through recent open market purchases.

Mat Ishbia and SFS Holding Corp. update their beneficial ownership in UWM Holdings, reflecting sales under a 10b5-1 plan.

Catherine Spear's latest Schedule 13D filing details a significant option repricing and a slight reduction in beneficial ownership due to tax-related share disposal.

FIGS co-founder Heather Hasson updated her beneficial ownership, including the repricing of over 3.5 million stock options to $6.63 per share.

Perceptive Advisors and affiliates updated their beneficial ownership in Lyra Therapeutics, Inc., now holding 15.55% of common stock.

LB Partners and its affiliated funds have reduced their beneficial ownership in WideOpenWest, Inc. to below 5% through recent share sales.

Lee Edward Changwu, a key insider, increased his beneficial ownership in Hestia Insight Inc. to 64.59% through recent open-market purchases, despite prior gifts.

Empro Group Inc.'s CEO and Chairman, Yeoh Chee Wei, reported beneficial ownership of 61.6% of the company's ordinary shares following the recent initial public offering.

An amendment to Schedule 13D details significant beneficial ownership stakes and recent stock transactions by key insiders and affiliated entities of OppFi Inc.

Compagnie Maritime Belge NV, a major shareholder in CMB.TECH NV, secured a $500 million loan facility, pledging its shares, and entered a share lending agreement to facilitate the Golden Ocean merger.

XCEL BRANDS, INC. CEO Robert W. D'Loren increased his beneficial ownership to 19.0% through recent share purchases and awards.

Mark Andrew Uram has significantly increased his beneficial ownership in Crypto Co to 17.2% of outstanding common stock, acquiring 672 million shares using personal funds.

Individual investor Mark Andrew Uram has increased his beneficial ownership in Crypto Co to 17.2% of common stock, holding 672 million shares.

Saba Capital Management, L.P. and its affiliates have reduced their beneficial ownership in Neuberger Berman Municipal Fund Inc. to 4.94% through recent open market sales.

ILJIN SNT and Seoung Eun Huh reduce their beneficial ownership in Aurinia Pharmaceuticals, bringing the group's total stake to 5.0%.

Bain Capital Life Sciences entities have significantly increased their beneficial ownership in X4 Pharmaceuticals to 9.99% following a new financing round and concurrent executive leadership changes.

JANA Partners Management, LP has increased its beneficial ownership in Rapid7, Inc. to 10.1% of outstanding shares, acquiring additional shares through open market transactions.

Robert Gregory Kidd and Goldeneye 1995 LLC have acquired a controlling 93.1% stake in Know Labs, Inc. through a private placement.

WideOpenWest, Inc. has entered into a definitive merger agreement to be acquired and taken private by a consortium led by Crestview Partners and DigitalBridge Investments for $5.20 per share in cash.

Andrew Dudum, CEO of Hims & Hers Health, Inc., has updated his beneficial ownership to 10.3% of the Class A common stock, reflecting a significant insider stake.

V2X's largest shareholder, Vertex Holdco, sold 2 million shares, leading to reduced board representation and loss of key consent rights.

OrbiMed Advisors and affiliated entities reported a decrease in their beneficial ownership of ArriVent BioPharma, Inc. common stock to 7.5% due to an increase in the issuer's outstanding shares.

Versant Venture Capital funds filed an amended Schedule 13D, updating their beneficial ownership in Tempest Therapeutics, Inc. due to dilution from recent share sales.

EverQuote, Inc. repurchased 900,000 shares of Class A Common Stock from Link Ventures LLLP for $20.997 million, with key holders entering a 180-day lock-up agreement.

Casdin Capital, a key investor, has increased its beneficial ownership in BioLife Solutions, Inc. to 15.0% through a recent share acquisition.

Christina Byland has significantly increased her beneficial ownership in RedCloud Holdings plc to 40.95% through a private placement.